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Alpers-Huttenlocher syndrome (AHS), ﬁrst described over 80
years ago is an autosomal recessive neurodegenerative disorder
characterised by the triad of refractory seizures, neuro-develop-
mental regression and hepatic failure.1 AHS is now known to be
caused by mutations in the gene encoding the catalytic subunit of
polymerase gamma (POLG1), an important mitochondrial DNA
replication enzyme.1 The phenotypes of AHS and other phenotypes
caused by POLG1 mutations have expanded to include atypical and
often diagnostically elusive presentations with variable age of
onset, disease severity and progression.1 Awareness of the
individual expression and wider constellation of signs is important
for diagnosis.
Epileptic seizures in AHS are usually partial, secondary
generalised tonic-clonic or myoclonic, with occipital lobe
predilection. In many cases, children present with refractory
status epilepticus or continuous focal motor seizures (epilepsia
partialis continua).1 A distinctive electroencephalogram
(EEG) pattern, posterior rhythmic high-amplitude delta with
superimposed polyspikes (RHADS) is very suggestive of the
diagnosis.1
We describe with video-EEG, a previously normal infant who
presented with explosive-onset profound hypotonia and bilateral
non-epileptic jerks, ultimately found to have AHS. The presenta-
tion outlined has not been previously reported.
2. Case
A 10-month-old boy, with a normal perinatal history and
developmental milestones presented following a mild coryzal* Corresponding author. Tel.: +353 01 878 4604; fax: +353 01 8784444.
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http://dx.doi.org/10.1016/j.seizure.2013.07.005illness with explosive-onset continuous, asymmetrical jerk-like
movements involving the proximal shoulders, arms, lower limbs
and neck. Initial examination revealed profound generalised
hypotonia with preservation of deep tendon reﬂexes, normal
eye movements and visual attention. Postnatal acquired micro-
cephaly was noted (25th to below 0.4th percentile). He was treated
empirically with intravenous acyclovir and cefotaxime, intubated-
ventilated and transferred to the intensive care unit.
Despite treatment with combinations of diazepam, lorazepam,
paraldehyde, phenobarbitone, fosphenytoin and midazolam the
jerks persisted in wakefulness and sleep (Video-EEG 1). The jerks
were rhythmic, occurring at approximately 1 Hz. Clinically, the
jerks were not typical of cortical myoclonus (<100 ms) or tonic
seizures (seconds)2 with a duration of approximately 350 ms
timed by visual analysis of the video-EEG. EEG background was
slow but there was no epileptiform activity on continuous video-
EEG monitoring (Fig. 1 and Video-EEG 1). Introduction of
thiopental and paralytic agents abolished the jerks, which
reappeared on withdrawal of these agents along with the
presenting clinical state.
Cerebrospinal ﬂuid (CSF) analysis showed normal lactate with
elevated protein (516 mg/dL), lymphocytosis (49 mm3) and
enterovirus DNA. Magnetic resonance imaging of the brain
including spectroscopy and spine were normal. Extensive inves-
tigations for metabolic disease and other infective or autoimmune
encephalitides were negative. Over the following weeks, sedative
agents were weaned while courses of other therapies (levitir-
acetam, carbamazepine, sodium valproate, corticosteroids and
intravenous immunoglobulin) also had no beneﬁt. The jerks were
continuous, rhythmic, asymmetrical and high amplitude. The
infant was very alert and visually interactive but profoundly
hypotonic with paucity of voluntary movement. EEG remained
without epileptiform changes.
On Day 33 of the illness, facial twitching emerged with EEG
showing periodic lateralised epileptiform discharges in the fronto-
central regions and characteristic RHADS (Fig. 2). Clonic jerking
with bilateral epilepsia partialis continua (EPC) and complex
partial seizures were noted (Video-EEG 2). Repeat CSF showed
increased lactate (3.22 mmol/L) and further elevated protein
(614 mg/dL). Sequencing of POLG1 revealed a compound hetero-
zygous in trans mutation (A467T/T914P). Liver function was
normal at presentation, with only mild elevation of AST (94 U/L)
terminally. The patient died from respiratory failure 68 days
following illness onset.vier Ltd. All rights reserved.
Fig. 1. EEG at presentation showing generalised slowing (maximum posteriorly) with superimposed fast (beta) activity due to medication. No EEG changes with clinical jerks,
no clinical or electrographic seizures were identiﬁed. See also Video-EEG 1.
Fig. 2. EEG recording (Day 33) demonstrating slowing of the background. Ongoing periodic lateralised epileptiform discharges seen mainly in the fronto-central regions
bilaterally. There is development of poly-spike/poly-sharp character to the periodic discharges in the later half of the recording (i.e. rhythmic high amplitude delta with
superimposed poly-spikes or RHADS). See also Video-EEG 2.
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Conﬁrming a diagnosis of AHS by testing for POLG1 mutations
is facilitated when EPC is associated with liver dysfunction at
presentation. The absence of hepatic dysfunction and EEG changes
early in the course in this case, coupled with CSF lymphocytosisand enterovirus isolation delayed POLG1 testing before an in trans
compound heterozygous mutation was ultimately identiﬁed,
harbouring a severe and unusual phenotype.
There are several reports of myoclonus and other hyperki-
netic movement disorders without EEG correlate later in the
course of POLG1-related disorders. The phenomenology and
N.M. Allen et al. / Seizure 23 (2014) 237–239 239evolution of the hyperkinetic movements observed in this case
over such a prolonged period of time is unusual. The movements
involved the neck and proximal limbs and were jerk-like,
although their duration at 350 ms appeared longer than
cortical myoclonus and shorter than tonic seizures.2 Further-
more, the EEG lacked epileptiform activity for 33 days before
emerging.
Jerk duration may be conﬁrmed with electromyography
(EMG) and is often longer in subcortical myoclonus (closer to
300 ms) when compared to cortical (epileptic) myoclonus.3 In
this case the jerks likely represent subcortical phenomena
involving the deep nuclei (thalamic or brainstem) as part of an
established or evolving mitochondrial encephalopathy although
it is a limitation that EMG was not performed. Enterovirus has
also been associated with acute neurological syndromes and
myoclonus, but the clinical signs are different to those observed
in this case where the jerks and presentation were likely a
manifestation of underlying mitochondrial dysfunction, trig-
gered by intercurrent infection.4
Hypotonia is a recognised feature in AHS usually in association
with epileptic seizures or encephalopathy. Despite profound
hypotonia (with preserved deep tendon reﬂexes) and non-
epileptic jerks continuous for one month, this infant remained
alert and visually interactive. The presentation described i.e.
explosive onset repetitive non-epileptic jerks and profound
hypotonia without impaired conciousness is a clinical description
that has not been previously reported in AHS. Albeit in this case
associated with enterovirus infection, POLG1 mutations should be
considered in infants with this presentation.Financial disclosures
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Appendix A. Supplementary data
Supplementary material (Video EEG1 and 2) related to this article
can be found, in the online version, at http://dx.doi.org/10.1016/
j.seizure.2013.07.005.
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